A detailed examination of China's increasingly important chemical and pharmaceutical industry. Numerous case studies describe how western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
From the reviews: "China, with its potential market of 1.3 billion consumers, has resurrected the western world's stagnant economic outlook. ... This is an interesting book on the global chemical industry and the business practices of multinational companies." (Helmut Hügel, Chemistry in Australia, December, 2005)